ABSTRACT
The self-organization and mobilization of active drugs users is historically four decades old, but is rarely noted in the addiction, or drug policy literature. This piece looks closely at three European countries that have had varying degrees of success in organizing injection drugs users as key stakeholders in the development of non-criminalizing drug and reintegrating social policies. Indeed, the core questions here are about whether drugs users organizations can, or do have any impact in the improvement of drug treatment as well as the policies, which ultimately govern their lives. It should be noted that all of the groups studied included a few ex-users and/or non-user allies.
Subject(s)
Consumer Advocacy , Consumer Organizations/organization & administration , Drug Users/legislation & jurisprudence , Public Policy/legislation & jurisprudence , Substance Abuse, Intravenous/therapy , Christianity , Europe , Harm Reduction , Health Policy , Humans , Legislation, Drug , Qualitative ResearchABSTRACT
The relationship between injection drug use and HIV was established early in the HIV epidemic, and injection drug use has continued to be an important risk factor for HIV throughout the world. This panel included 4 papers related to HIV prevention among drug users, focusing on effective prevention strategies, the importance of organizing the AIDS-affected community, the impact of knowledge of serostatus on risk behaviors, and developing interventions for drug-using homosexual and bisexual men. These papers, addressing various aspects of the epidemic and methods to enhance prevention efforts, all indicate that although extensive knowledge regarding how to reduce HIV risks among drug users has accumulated, many areas for further research and intervention development remain.
